Literature DB >> 16160804

Severe diabetic fetopathy despite strict metabolic control.

Heinz Leipold1, Christof Worda, Jens Schwindt, Alexandra Kautzky-Willer, Dagmar Bancher-Todesca, Peter W Husslein.   

Abstract

In pregnant women, diabetes mellitus (DM) can cause severe complications for both mother and child during pregnancy and delivery; for example, hypertension, pre-eclampsia, macrosomia or intrauterine fetal death. It is therefore essential to achieve good metabolic control in the mother from before conception to the postpartum period. A 35-year-old primipara with type 2 DM presented herself at our outpatient department at 21 weeks of gestation. Until this time her DM had been treated with oral antidiabetic drugs; these were withdrawn and conventional insulin therapy was initiated. Except for the first two weeks after insulin adjustment, blood glucose values were within the required range. Biometric tests performed until week 30 of gestation showed discreet fetal growth. In the week 31, fetal abdominal girth near the 95% limit was observed for the first time; this was soon followed by an explosion-like enlargement of the abdomen along with glycemic values at the lower limit. A cesarean section was performed in week 35 of gestation because of the excessive macrosomia. The female newborn had a birth weight of 4920 g and, one hour after delivery, a blood glucose of 10 mg/dl requiring an intravenous glucose bolus. In addition, the child needed oxygen and also needed both an enteral and a parenteral supply of glucose until day 7 after delivery. Mother and child were discharged from the clinic 19 days postpartum in good general condition. This case illustrates the complexity of treatment of glucose-tolerance disturbances during pregnancy and underlines the importance of fetal monitoring by ultrasound, given that measurement of maternal blood glucose does not always provide sufficient information on the metabolic situation of the fetus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160804     DOI: 10.1007/s00508-005-0412-1

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  5 in total

1.  The insulin analog glargine during an unplanned pregnancy.

Authors:  Daniela Cechurová; Silvie Lacigová; Zdenĕk Jankovec; Iva Haladová; Michal Zourek; Michal Krcma; Zdenĕk Rusavý; Jirí Turek
Journal:  Wien Klin Wochenschr       Date:  2006-10       Impact factor: 1.704

2.  Fetal Interventricular Septum Volume Evaluated by Three-Dimensional Ultrasound Using Spatiotemporal Image Correlation and Virtual Organ Computer-Aided Analysis in Fetuses From Pre-Gestational Diabetes Mellitus Pregnant Women.

Authors:  Nathalie Jeanne Bravo-Valenzuela; Alberto Borges Peixoto; Rosiane Mattar; Edward Araujo Júnior
Journal:  J Cardiovasc Imaging       Date:  2022-04

3.  Association of Proteins Modulating Immune Response and Insulin Clearance During Gestation with Antenatal Complications in Patients with Gestational or Type 2 Diabetes Mellitus.

Authors:  Arthur T Kopylov; Anna L Kaysheva; Olga Papysheva; Iveta Gribova; Galina Kotaysch; Lubov Kharitonova; Tatiana Mayatskaya; Anna Krasheninnikova; Sergey G Morozov
Journal:  Cells       Date:  2020-04-21       Impact factor: 6.600

4.  Molecular pathophysiology of diabetes mellitus during pregnancy with antenatal complications.

Authors:  Arthur T Kopylov; Olga Papysheva; Iveta Gribova; Galina Kotaysch; Lubov Kharitonova; Tatiana Mayatskaya; Ekaterina Sokerina; Anna L Kaysheva; Sergey G Morozov
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

5.  Prediction of Fetal Hypertrophic Cardiomyopathy in Diabetic Pregnancies Compared with Postnatal Outcome.

Authors:  Sherif F Elmekkawi; Ghada M Mansour; Mohammed S E Elsafty; Alaa S Hassanin; Mohamed Laban; Heba M Elsayed
Journal:  Clin Med Insights Womens Health       Date:  2015-12-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.